Although the patterns of bone involvement differ in rheumatoid arthritis (RA) and axSpA, the final common pathway of bone loss in both cases is increased osteoclastic bone resorption which is critically dependent on the stimulatory effects of RANKL, counterbalanced by the inhibitory effects of OPG [11]. The gene discussed is TNFRSF11B; the disease is rheumatoid arthritis.